Cara Therapeutics Inc (NAS:CARA)
$ 0.378 -0.0719 (-15.98%) Market Cap: 20.73 Mil Enterprise Value: -13.94 Mil PE Ratio: 0 PB Ratio: 37.80 GF Score: 35/100

Cara Therapeutics Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 09:00PM GMT
Release Date Price: $9.22 (+23.76%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Let's get started, and we'll get all in. So good day, everybody. Thanks for joining us at the Bank of America Annual Healthcare Conference in Las Vegas. My name is Jason Gerberry, I'm one of the biotech analysts at BofA, and I'm pleased to be introducing Cara Therapeutics and CEO, Chris Posner. So Chris, thanks so much for joining us at the conference.

Christopher A. Posner
Cara Therapeutics, Inc. - President, CEO & Director

Yes, Jason, thanks for having us.

Questions & Answers

Jason Matthew Gerberry;Christopher A. Posner
BofA Securities, Research Division - MD in US Equity Research;Cara Therapeutics, Inc. - President, CEO &

Yes. So great. So maybe I don't know if you wanted to coming off the quarter and 6 months into the gig as CEO of Cara, maybe what are your initial observations? And maybe just kind of set the agenda for the rest of the year, what you're most excited about?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot